
Pioneering AI Drug Discovery | Recursion
All of our results feed back into our drug discovery and drug development platform – the Recursion Operating System – in a continuously improving feedback loop.
Recursion's Drug Discovery Pipeline | Recursion
Leveraging the power of the Recursion OS, we are building an industry-leading pipeline of potential best-in-class and first-in-class therapeutic assets. We focus on indications with high unmet need, …
Our Unique Approach to AI Drug Discovery | Recursion
Unlike traditional drug discovery, which begins with a specific target or hypothesis, we leverage the Recursion OS — our drug discovery and development platform for AI in pharma connects technical …
Our AI Drug Discovery & Development Story | Recursion
Nov 5, 2013 · We are not here to make a few medicines. We are here to reimagine how medicines are made. The Recursion mindset is the deep belief and commitment to industrializing drug discovery …
Careers at Recursion: Join Our Mission | Recursion
Embark on a career journey with Recursion. Dive into opportunities, culture, and the impact you can make. Apply to work with us today!
AI-Driven Drug Discovery Insights | Recursion
Dec 4, 2025 · Explore Recursion's latest blog posts on AI, automation, and molecular modeling in drug discovery. Stay informed with cutting-edge insights!
Recursion Pharmaceuticals, Inc.
Oct 28, 2025 · Recursion leverages sophisticated machine-learning algorithms to distill from its dataset a collection of trillions of searchable relationships across biology and chemistry unconstrained by …
Recursion Announces Completion of NVIDIA-Powered BioHive-2, the …
May 13, 2024 · Recursion is headquartered in Salt Lake City, where it is a founding member of BioHive, the Utah life sciences industry collective. Recursion also has offices in Toronto, Montreal and the …
Press Releases & Recursion News | Recursion
Sep 1, 2017 · Stay updated with the latest press releases and news from Recursion. Dive into our achievements, announcements, and more. Explore now!
Recursion Pharmaceuticals, Inc. - Preliminary Phase 1b/2 Data for REC ...
May 4, 2025 · Recursion leverages sophisticated machine-learning algorithms to distill from its dataset a collection of trillions of searchable relationships across biology and chemistry unconstrained by …